New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance : vimarsana.com

RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures

Related Keywords

Thailand , United States , American , , Aveon Health Scottsdale , Precision Diabetes Inc , American Diabetes Association , Precision Diabetes , Scientific Sessions , Anhydroglucitol Values , Patients Taking , Waveon Health , Thailand Business ,